Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients

American Journal of Gastroenterology

Volumn 99, Issue 9, 2004, Pages 1708-1717

  Ribeiro, Paulo S ^b   Cortez Pinto, Helena ^b   Solá, Susana ^b   Castro, Rui E ^b   Ramalho, Rita M ^b   Baptista, Amélia ^b   Moura, Miguel C ^b   Camilo, Maria E ^b   Rodrigues, Cecília M P ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; UNCOUPLING PROTEIN 2;

ADULT; ALCOHOLIC FATTY LIVER; APOPTOSIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVATION; EVALUATION; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AMBULATORY CARE; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELLS, CULTURED; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HEPATOCYTES; HOSPITALIZATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; NF-KAPPA B; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; UP-REGULATION;

EID: 4544335155     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40009.x     Document Type: Article

References (46)

1. Brunt EM. Nonalcoholic steatohepatitis: Definition and pathology. Semin Liver Dis 2001;21:3-16.
2. Pessayre D, Berson A, Fromenty B, et al. Mitochondria in steatohepatitis. Semin Liver Dis 2001;21:57-69.
3. Goldin RD, Hunt NC, Clark J, et al. Apoptotic bodies in a murine model of alcoholic liver disease: Reversibility of ethanol-induced changes. J Pathol 1993;171:73-6.
4. Baroni GS, Marucci L, Benedetti A, et al. Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver. J Hepatol 1994;20:508-13.
5. Kurose I, Higuchi H, Miura S, et al. Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology 1997;25:368-78.
6. Natori S, Rust C, Stadheim LM, et al. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001;34:248-53.
7. Ziol M, Tepper M, Lohez M, et al. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001;34:254-60.
8. Papakyriakou P, Tzardi M, Valatas V, et al. Apoptosis and apoptosis related proteins in chronic viral liver disease. Apoptosis 2002;7:133-41.
9. Susca M, Grassi A, Zauli D, et al. Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in nonalcoholic steatohepatitis. Dig Liver Dis 2001;33:768-77.
10. Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology. 2003;125:437-43.
11. Barnes PJ, Karin M. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
12. Nanji AA, Jokelainen K, Rahemtulla A, et al. Activation of nuclear factor κ B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 1999;30:934-43.
13. Iimuro Y, Nishiura T, Hellerbrand C, et al. NF-κB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998;101:802-11.
14. Uesugi T, Froh M, Arteel GE, et al. Delivery of IκB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats. Hepatology 2001;34:1149-57.
15. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002;27:63-8.
16. Minana JB, Gomez-Cambronero L, Lloret A, et al. Mitochondrial oxidative stress and CD95 ligand: A dual mechanism for hepatocyte apoptosis in chronic alcoholism. Hepatology 2002;35:1205-14.
17. Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000;5:415-8.
18. Boss O, Hagen T, Lowell BB. Uncoupling proteins 2 and 3: Potential regulators of mitochondrial energy metabolism. Diabetes 2000;49:143-56.
19. Rashid A, Wu TC, Huang CC, et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 1999;29:1131-38.
20. Pinto HC, Baptista A, Camilo ME, et al. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 1996;41:172-9.
21. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;5:434-8.
22. Masson S, Scotte M, Garnier S, et al. Differential expression of apoptosis-associated genes post-hepatectomy in cirrhotic vs. normal rats. Apoptosis 2000;5:173-9.
23. Arsenijevic D, Onuma H, Pecqueur C, et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 2000;26:435-9.
24. Krauss S, Zhang CY, Lowell BB. A significant portion of mitochondrial proton leak in intact thymocytes depends on expression of UCP2. Proc Natl Acad Sci U S A 2002;99:118-22.
25. Baffy G, Zhang CY, Glickman JN, et al. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 2002;35:753-61.
26. Cortez-Pinto H, Chatham J, Chacko VP, et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study. JAMA 1999;282:1659-64.
27. Kurland JF, Kodym R, Story MD, et al. NF-κB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. J Biol Chem 2001;276:45380-6.
28. Bureau F, Vanderplasschen A, Jaspar F, et al. Constitutive nuclear factor-κB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins. Blood 2002;99:3683-91.
29. Heckman CA, Mehew JW, Boxer LM. NF-κB activates Bcl-2 expression in t(14; 18) lymphoma cells. Oncogene 2002;21:3898-08.
30. Lawson JA, Fisher MA, Simmons CA, et al. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury. Hepatology 1998;28:761-7.
31. Faouzi S, Burckhardt BE, Hanson JC, et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-κB-independent, caspase-3-dependent pathway. J Biol Chem 2001;276:49077-82.
32. Canbay A, Higuchi H, Bronk SF, et al. Fas enhances fibrogenesis in the bile duct ligated mouse: A link between apoptosis and fibrosis. Gastroenterology 2002;123:1323-30.
33. Ingelman-Sundberg M, Ronis MJ, Lindros KO, et al. Ethanol-inducible cytochrome P4502E1: Regulation, enzymology and molecular biology. Alcohol Alcohol Suppl 1994;2:131-9.
34. Lieber CS. Cytochrome P-4502E1: Its physiological and pathological role. Physiol Rev 1997;77:517-44.
35. Taieb J, Mathurin P, Poynard T, et al. Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease. Lancet 1998;351:1930-1.
36. Bird GL, Sheron N, Goka AK, et al. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917-20.
37. McClain CJ, Barve S, Deaciuc I, et al. Cytokines in alcoholic liver disease. Semin Liver Dis 1999;19:205-19.
38. Crespo J, Cayon A, Fernandez-Gil P, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001;34:1158-63.
39. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-8.
40. Jaeschke H. Inflammation in response to hepatocellular apoptosis. Hepatology 2002;35:964-6.
41. Jaeschke H, Fisher MA, Lawson JA, et al. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-α-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 1998;160:3480-6.
42. Tilg H, Jalan R, Kaser A, et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 2003;38:419-25.
43. Spahr L, Rubbia-Brandt L, Frossard J, et al. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: A randomized controlled pilot study. J Hepatol 2002;37:448-55.
44. Yin M, Wheeler MD, Kono H, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942-52.
45. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003;37:343-50.
46. Deaciuc IV, D'Souza NB, de Villiers WJ, et al. Inhibition of caspases in vivo protects the rat liver against alcohol-induced sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 2001;25:935-43.